mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer

MLA

Ling Tian, et al. “MTORC2 Regulates Ribonucleotide Reductase to Promote DNA Replication and Gemcitabine Resistance in Non-Small Cell Lung Cancer.” Neoplasia: An International Journal for Oncology Research, vol. 23, no. 7, July 2021, pp. 643–52. EBSCOhost, https://doi.org/10.1016/j.neo.2021.05.007.

APA

Ling Tian, Congcong Chen, Yanguan Guo, Fan Zhang, Jinye Mi, Qi Feng, Shengbin Lin, Naite Xi, Jiaxin Tian, Li Yu, Yan Chen, Mingrong Cao, Caiyong Lai, Jun Fan, Yongchang Zhang, & Guo Chen. (2021). mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer. Neoplasia: An International Journal for Oncology Research, 23(7), 643–652. https://doi.org/10.1016/j.neo.2021.05.007

Chicago

Ling Tian, Congcong Chen, Yanguan Guo, Fan Zhang, Jinye Mi, Qi Feng, Shengbin Lin, et al. 2021. “MTORC2 Regulates Ribonucleotide Reductase to Promote DNA Replication and Gemcitabine Resistance in Non-Small Cell Lung Cancer.” Neoplasia: An International Journal for Oncology Research 23 (7): 643–52. doi:10.1016/j.neo.2021.05.007.